Harnessing a cRGD-Targeted Schottky Junction MXene Nanocomposite for Potent Bladder Cancer Therapy: Dual-Modal PTT/PDT Effects with Immune Activation and Favorable Comparison to Doxorubicin Authors: Zhibo Gu, Hua Zhu, Yong Zhang, Jie Jiang, Donghua Gu, Jiangang Chen Published: 2026 ABSTRACT ObjectiveThis study developed a multifunctional MnFe2O4/TiVNbMoC3-cRGD (MXenes) nanocomposite for targeted photothermal- photodynamic therapy against bladder cancer.MethodsA multifunctional MXene-based nanocomposite was constructed by integrating MnFe2O4 nanoparticles onto TiVNbMoC3 MXene nanosheets to form a layer-on-layer Schottky junction, followed by conjugation of cRGD peptides for tumor targeting. Successful synthesis, colloidal stability, broad optical absorption, efficient photothermal conversion and ROS generation under 808 nm laser were confirmed. In vitro assays were conducted using 5637 bladder cancer cells, and a murine bladder tumor model was established to evaluate the anticancer efficacy. Biocompatibility assessments were also carried out.ResultsThe composite was constructed by integrating MnFe2O4 nanoparticles onto TiVNbMoC3 MXene nanosheets, which formed a layer - on - layer Schottky junction. Then, cRGD peptides were conjugated to the surface for tumor targeting. Comprehensive characterization confirmed successful synthesis, favorable colloidal stability, broad optical absorption, and efficient photothermal conversion and reactive oxygen species (ROS) generation under 808 nm laser irradiation. In vitro, the cRGD-targeted nanocomposite was efficiently internalized by 5637 bladder cancer cells and showed significantly higher anticancer efficacy than doxorubicin (DOX), including inhibition of proliferation, migration, colony formation, and induction of apoptosis and immunogenic cell death. In a murine bladder tumor model, the nanocomposite achieved the strongest tumor growth suppression and reduced final tumor volume more effectively than DOX. Biocompatibility assessments showed minimal hemolysis and no major organ damage at therapeutic doses.ConclusionThis MXene-based Schottky junction nanocomposite represents a promising targeted platform for dual-modal photothermal/photodynamic therapy combined with immune activation in bladder cancer, warranting further translational investigation. Introduction Bladder cancer is the sixth most common cancer in men, accounting for ~6% of new cancer cases.1 Current standard treatments (surgery and chemotherapy) improve early-stage survival but have major limitations: a 40–50% overtreatment rate, a formidable five-year recurrence rate of 50–70%, and an inherent risk of risk of progression to muscle invasive disease.2 Thus, these modalities often prove insufficient to prevent disease recurrence and progression, frequently compromising patients’ long-term quality of life. There is, an urgent clinical need for more effective strategies. In this context, novel treatment modalities such as photodynamic therapy (PDT), photothermal therapy (PTT), chemodynamic therapy (CDT), and immunotherapy have emerged as promising alternatives or complements to conventional oncology regimens.3–5 These approaches offer distinct mechanisms of action and can be engineered to act synergistically, making multimodal combination therapy a pivotal strategy capable of producing superior therapeutic outcomes often exemplifying a remarkable “1+1>2” effect-compared to monotherapies or their simple superposition.6,7 For instance, in bladder cancer, Chen et al8 enhanced bladder cancer therapy by combining PTT with glucose fueled CDT and GSH depletion to remodel the TME. Nanotechnology provides a powerful toolkit to rationally design and implement such synergistic strategies. Schottky junction nanocatalysts (metal-semiconductor interfaces) efficiently manage photogenerated charge carriers.9 Their catalytic reactions mechanism involves: (i) light induced electron‑hole pair generation, (ii) charge separation driven by the Schottky barriers built in electric field (suppressing recombination),10 and (iii) surface reactions generating cytotoxic reactive oxygen species (ROS).11 ROS bursts trigger immunogenic cell death (ICD), releasing tumor antigens and damage‑associated molecular patterns to initiate adaptive immunity.12 This principle has succeeded in type II heterojunctions and Au@CuS nanoparticles.13,14 Furthermore, Chen H. et al15 optimized an MXene@TiO2/Fe3O4 Schottky platform for exosome based bladder cancer detection. Given ongoing challenges of drug resistance and off target toxicity, integrating the unique advantages of Schottky junction nanocatalysts into the therapeutic paradigm presents a compelling avenue.16 A nanocatalyst leveraging accelerated photoelectrodynamic processes could achieve precise tumor eradication while mitigating conventional treatment drawbacks.5 This study develops such a Schottky junction based nanocatalytic platform and rigorously evaluates its efficacy against bladder cancer. Methods and Materials Synthesis and Characterization Synthesis of TiVNbMoC3 MXene TiVNbMoC3 MXene was synthesized by selectively etching the aluminum layer from the TiVNbMoAlC3MAX phase. Specifically, the MAX powder was added to 50 mL of 48 wt% hydrofluoric acid (HF) and continuously stirred at 55 °C and 400 rpm for 4 days. The resulting mixture was then washed repeatedly with deionized water via centrifugation (4000 rpm, 3–5 min per cycle) until the supernatant reached a neutral pH (6–7). The sediment was subsequently treated with 5 wt% tetramethylammonium hydroxide (TMAOH) and stirred at 55 °C for 4 h to achieve delamination. Finally, the single-layer MXene nanosheets were collected from the supernatant and obtained by freeze-drying. (The MAX precursor and etching reagents were sourced from Beike Nanotechnology Co., Ltd., Suzhou, China). Synthesis of MnFe2O4 Nanoparticles MnFe2O4 nanoparticles were prepared via a hydrothermal method. First, 0.495 g (2.5 mmol) of MnCl2·4H2O (Aladdin Biochemical Technology Co., Ltd., Shanghai, China) was dissolved in 40 mL of an aqueous solution containing 1.35 g (5 mmol) of FeCl3·6H2O under stirring for 1 h. A predetermined volume of NaOH solution was then added dropwise until a black precipitate formed. The mixture was transferred into a Teflon-lined stainless-steel autoclave and heated at 200 °C for 24 h. After cooling, the product was collected by centrifugation, washed alternately with deionized water and ethanol, and dried in an oven at 60 °C for 12 hours. Fabrication of MXenes Nanocomposite To prepare the final nanocomposite, a chitosan solution was first prepared by dissolving 0.5 g of chitosan in 100 mL of 2% glacial acetic acid with stirring at 65 °C for 20 minutes. Then, 0.1 g of the as-synthesized MnFe2O4 nanoparticles and 10 mL of a TiVNbMoC3 MXene aqueous dispersion (10 mg/mL) were added to the chitosan solution. The mixture was stirred at 60 °C for 10 minutes and then allowed to stand overnight. The resulting product, MnFe2O4/TiVNbMoC3, was collected by centrifugation, washed several times with distilled water, and freeze-dried. Finally, cRGD peptides were immobilized onto the nanocomposite surface via π-π stacking and electrostatic interactions to form MXenes, which was stored at 4 °C for subsequent use. The resulting structure features a layer-on-layer Schottky junction. Stability and Storage Synthesis and handling: All MXene synthesis and exfoliation steps are carried out under argon atmosphere in a glovebox to minimize oxygen exposure. Storage: The as-prepared TiVNbMoC3 MXene nanosheets are lyophilized and stored as a powder under vacuum at −20°C in amber vials. For colloidal dispersions, the MXene is freshly dispersed in deoxygenated deionized water or PBS (pH ~7.4) immediately before use. Stability validation: We regularly characterize the material by XPS to monitor surface oxidation (eg, TixOy formation) and UV-vis-NIR to track the characteristic absorption peak. Typically, the material remains stable for at least one week under these conditions. Transport: For inter-laboratory transport, the powder is sealed under argon in a double‑layered vial with desiccant and shipped on dry ice. Colloidal Characterization Colloidal stability was evaluated via the Tyndall effect. Briefly, 800 µL of the nanocomposite suspension and 800 µL of PBS (control) were separately placed in Eppendorf tubes. A laser pointer was used to irradiate each tube. A clear visible beam path in the nanocomposite suspension, absent in the PBS control, indicated good dispersibility and colloidal stability. Detection of ROS ROS generation was measured using 1,3‑diphenylisobenzofuran (DPBF) as a probe. First, 1.2 mL of MnFe2O4/TiVNbMoC3 solution (100 µg/mL) and PBS control was mixed with 10 µL of DPBF ethanolic solution (100 µM). The mixture was transferred to a quartz cuvette and irradiated with an 808 nm laser (1 W/cm2). The decomposition of DPBF was monitored by recording the decrease in absorbance at 410 nm at 1-min intervals for 7-min. Photothermal Performance Measurement with 808 nm Laser The photothermal performance of the nanocomposite was evaluated under 808 nm near-infrared (NIR) laser irradiation. The material’s aqueous dispersions and pure water (control) were placed in separate vessels. Temperature changes were monitored in real-time using an infrared thermal camera. In vitro Cellular Assays Cell Culture Human bladder cancer 5637 cells (C6018, Beyotime Biotechnology Co., Ltd., China) were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific, USA) supplemented with 10% fetal bovine serum. Cells were maintained at 37 °C in a humidified atmosphere containing 5% CO2. Cell Viability Assay Cell viability was assessed using the Cell Counting Kit8 (CCK-8, C0038, Beyotime). Cells were seeded in 96-well plates at approximately 60% confluence and treated with various concentrations of nanomaterials (TiVNbMoC3, MnFe2O4/TiVNbMoC3 and MnFe2O4/ TiVNbMo C3-RGD) for 48 h under 808 nm laser irradiation. Thereafter, CCK-8 reagent was added to each well and incubated at 37 °C for 1 h. Absorbance was measured at 450 nm using a microplate reader. Cell viability was calculated as follows: Cell Viability (%) = [(OD_Experimental − OD_Blank) / (OD_Control − OD_Blank)] × 100. Cellular Uptake Cells grown on coverslips were treated with the nanocomposite (25 µg/mL) for 0, 2, 4, 8, or 12 h. After treatment, cells were washed with PBS and further cultured for 24 h. Cell membranes were labeled with DiO (green fluorescence, C1038, Beyotime) by incubation at 37 °C for 60 min, and nuclei were stained with DAPI (blue fluorescence, C1006, Beyotime) for 5 min. The intracellular localization of the Cy5.5‑labeled nanocomposite (red fluorescence) was visualized using confocal laser scanning microscopy. Co‑localization with membrane (green) and nuclear (blue) signals was analyzed to evaluate uptake efficiency and time dependence. Cytotoxicity Assay (Calcein AM/PI Staining) Cytotoxicity was evaluated using a Calcein AM/PI Cell Viability/Cytotoxicity Assay Kit. Cells were seeded in a 24-well plate at ~60% confluence and treated with nanomaterials (50 μg/mL) for 48 hours. Following treatment, the cells were washed with PBS and further cultured in complete medium for 24 hours. The culture medium was then removed, and the cells were washed once with PBS before being incubated with an appropriate volume of the Calcein AM/PI working solution for 30 minutes at 37°C. After incubation, aspirate the solution and wash the cells three times with pre-warmed culture medium. Staining was visualized under a fluorescence microscope, with Calcein AM (green fluorescence, Ex/Em=494/517 nm) indicating live cells and PI (red fluorescence, Ex/Em=535/617 nm) indicating dead cells. Colony Formation Assay Cells were seeded into 6-well plates at an initial density of 60%. After treatment with the nanomaterials (25 μg/mL), the cells were cultured until visible colonies had formed. The culture medium was then removed, and the cells were gently washed with PBS, fixed with 4% paraformaldehyde for 20 min, and stained with crystal violet for another 20 min. Following a final PBS wash and air-drying, the colonies were photographed and counted to evaluate the long-term proliferative capacity and clonogenic survival of the cells. Scratch Wound Healing Assay Cell migration was assessed using a scratch wound healing assay. Cells were seeded in a 6-well plate at 60% confluence and treated with nanomaterials (25 μg/mL) for 48 hours. After treatment, the cells were washed with PBS and cultured in serum-free medium for 6 hours. A straight scratch was then gently created across the cell monolayer using a sterile pipette tip. The initial wound (0 hours) was imaged under an inverted microscope. The cells continued to be cultured in serum-free medium for another 48 hours, after which the same locations were re-imaged to assess wound closure. Apoptosis Assay Cell apoptosis was analyzed using an Annexin V-APC Apoptosis Detection Kit by flow cytometry. Cells were seeded in a 6-well plate at 60% confluence and treated with nanomaterials (50 μg/mL) for 48 hours. After treatment, the adherent cells were washed with PBS, detached using trypsin, and collected by centrifugation at 1000 rpm for 5 minutes. The cell pellet was gently resuspended in PBS and counted. Subsequently, 100,000 cells were centrifuged again, resuspended in Annexin V-binding buffer (AP107 MultiSciences Biotech Co., Ltd), and stained with 10 μL of propidium iodide (PI) solution (C2015M, Beyotime Co., Ltd). The cells were incubated at room temperature (20–25°C) in the dark for 10 minutes. Finally, the samples were placed on ice and immediately analyzed by flow cytometry. Western Blot Analysis Bladder cancer cells were treated according to different experimental groups different experimental groups (PBS control, TiVNbMoC3 group, DOX group (0.2uM), MnFe2O4/ TiVNbMoC3 -RGD + 808 nm laser irradiation (1.0 W/cm2, 10 min) group). Proteins were extracted using RIPA lysis buffer containing protease inhibitors. Protein concentration was determined with a BCA assay. Equal amounts of protein were separated by SDS-PAGE and transferred onto PVDF membranes. Membranes were blocked with 5% skim milk and incubated overnight at 4 °Cwith primary antibodies against high-mobility group box 1 (HMGB1, 10,829-1-AP), calreticulin,(CRT, 27298-1-AP), and GAPDH (14751-1-AP; all from Sanying Biotechnology Co., Ltd., Wuhan, China). After incubation with HRP-conjugated secondary antibodies, protein bands were visualized using an ECL substrate and quantified by densitometry, with GAPDH as the loading control. In vivo Antitumor Efficacy and Biosafety Evaluation Establishment of Bladder Tumor Model and Treatment Protocol All animal procedures followed the National Institutes of Health guidelines and were approved by the Animal Ethics Committee of Nantong University (Approval No. S20251225-001). Male BALB/c mice (4–6 weeks old, weighing 18–22 g) were were inoculated subcutaneously with 5×106 5637 bladder cancer cells in the right flank. When tumors reached approximately 50 mm3 (around day 7 post inoculation), mice were randomly assigned into four treatment groups (n = 5 per group): (1) PBS control, (2) TiVNbMoC3MXene only (100 µg/mL), (3) DOX (2 mg/kg, intraperitoneal injection every 2 days), (4) MnFe2O4/TiVNbMoC3- cRGD nanocomposite (100 µg/mL, intratumoral injection) + 808 nm laser irradiation (1.0 W/cm2, 10 min). The sample size (n = 5 per group) was determined based on a power analysis assuming a medium effect size (Cohen’s d = 0.8), α = 0.05 (two-tailed test), and a desired power of 80%, which yielded a minimum requirement of 5 mice per group, consistent with previously published guidelines for preclinical tumor xenograft models.17 Tumor volumes were measured every 3 days using a digital caliper and calculated as V = (length × width2)/2. The experimenter performing tumor measurements was blinded to group allocation. At the end of the study (day 14), mice were euthanized, and tumors and major organs were harvested for further analysis. Immunohistochemical Analysis of Tumor Tissues TUNEL Staining for Apoptosis Detection Tumor tissue sections were deparaffinized in xylene, rehydrated through a graded ethanol series, and rinsed with PBS. After permeabilization with Proteinase K (20 µg/mL, ST535, Beyotime) for 20 min at room temperature and washing, then sections were equilibrated with 1x Equilibration Buffer for 10–30 min. The TdT reaction mixture was then applied, and slides were incubated at 37 °C for 60 min in a humidified chamber. Following a PBS wash, nuclei were counterstained with DAPI (2 µg/mL, C1006, Beyotime) for 5 min at RT. After a final wash, slides were immediately imaged under a fluorescence microscope (TUNEL signal: 520±20 nm; DAPI: 460 nm). Ki-67 Immunofluorescence Staining for Proliferation Assessment We evaluated tumor proliferation by staining for the Ki-67 antigen. Following deparaffinization and rehydration, tissue sections underwent antigen retrieval. After blocking the non-specific binding sites, the tissue sections were incubated with an anti - Ki - 67 primary antibody (1:200, AG2646, Beyotime) overnight at 4 °C. After washing, a fluorescently labeled secondary antibody was applied. Nuclei were counterstained with DAPI, and slides were imaged using a fluorescence microscope. Parallel sections were stained with hematoxylin and eosin (H&E) for general histopathological evaluation. Biosafety Evaluation Hemolysis Assay The hemolysis assay was performed as follows. First, red blood cells (RBCs) were isolated from 1 mL of human whole blood. The blood was diluted with 2 mL of 1x PBS and centrifuged at 500 g for 10 minutes; this purification step was repeated five times. Subsequently, the isolated RBCs were adjusted to a concentration of 2.5×106 cells mL−1 using 1x PBS. To obtain six final concentrations (5–200 µg mL−1), 200 µL of this RBC suspension was added to 800 µL of the Schottky junction composite suspension for the test. All mixtures, along with positive (deionized water) and negative (1xPBS) controls, were incubated at 37°C for 3 hours on a shaker. Following incubation, the samples were centrifuged at 10,050 rpm for 5 minutes, and the hemoglobin release was quantified by measuring the absorbance of the supernatant at 540 nm. Histopathological Analysis of Major Organs To assess systemic toxicity, we harvested major organs (heart, liver, spleen, lungs, and kidneys) were harvested from tumor-bearing mice at the endpoint of the study. Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin, and sectioned at 4 µm thickness. Sections were stained with H&E and examined under a light microscope for any signs of histopathological abnormality. Results Synthesis and Characterization of MnFe2O4/TiVNbMoC3 Nanozyme The MnFe2O4/TiVNbMoC3 nanozyme was successfully synthesized, as outlined in Scheme 1. Its morphology was examined by scanning electron microscopy (SEM, Figure 1A) and transmission electron microscopy (TEM, Figure 1B). As shown, TiVNbMoC3 serves as a substrate, forming a uniform matrix on which MnFe2O4/TiVNbMoC3 nanoparticles are evenly deposited. High-magnification images (Figure 2) reveal no significant phase separation or large-scale agglomeration, confirming the successful formation of a well-integrated composite. Scheme 1Synthesis and Characterizations of the Schottky Junction Semiconductor Nanocatalysts MnFe2O4/ TiVNbMoC3.Synthesis pathway of MnFe2O4/TiVNbMoC3-RGD nanocatalysts showing stepwise chemical reactions and conditions.The synthesis pathway for MnFe2O4/TiVNbMoC3-RGD nanocatalysts starts with TiVNbMoAlC3 reacting with 48% hydrofluoric acid at 400 rpm for 4 days at 55°C, forming TiVNbMoC3. This is treated with 5% tetramethylammonium hydroxide at 500 rpm for 4 hours at 55°C, then at 10000 rpm for 5-10 minutes at pH 6, yielding TiVNbMoC3 (High-entropy). Arg-Gly-Asp is added for 10 minutes at 60°C to produce MnFe2O4/TiVNbMoC3-RGD. Separately, manganese chloride dihydrate and iron chloride hexahydrate react with sodium hydroxide at pH 12 for 24 hours at 200°C, followed by magnetic separation and heating for 12 hours at 60°C to form MnFe2O4. This compound is treated with chitosan (acetic acid) and glutaric dialdehyde for 20 minutes at 60°C, then exposed to UV light for 35 minutes, resulting in MnFe2O4 nanoparticles.Figure 1(A) SEM image of MnFe2O4/TiVNbMoC3 composite material. MnFe2O4 adhere to the surface of TiVNbMoC3 lamellar layers, manifesting as clusters of aggregated particles due to its magnetic properties. (B) TEM image of the composite of TiVNbMoC3 monolayer and MnFe2O4 nanoparticles. The dark areas in the image represent MnFe2O4, which is clearly bound to the surface of the TiVNbMoC3 monolayer, indicating successful synthesis of the composite material.Composite micrograph: two grayscale electron images (A, B) show irregular aggregates on dark/light backgrounds.Figure 2The distribution of Mn (dark green) and Fe (light green) elements closely overlaps, confirming the formation of MnFe2O4. The distribution of oxygen (pink) is somewhat correlated with that of Mn and Fe, but it is also present in other regions, potentially indicating partial oxidation on the sample surface.Microscopy figure: 9 dot-map micrographs in 3x3 grid, 1 multicolor overlay, 8 single-color element maps.Image A: Multicolor elemental overlay micrograph with dense multicolored dots and bright clusters on a dark background. Element symbols are shown in a legend at the lower left. Scale bar: 2 micrometers. Image B: Sodium dot map with yellow dots scattered and some dense groupings on black. Scale bar: 2 micrometers. Image C: Magnesium dot map with blue dots scattered on black. Scale bar: 2 micrometers. Image D: Molybdenum dot map with sparse green dots and clusters on black. Scale bar: 2 micrometers. Image E: Silicon dot map with cyan dots and dense clusters on black. Scale bar: 2 micrometers. Image F: Nickel dot map with yellow dots and clusters on black. Scale bar: 2 micrometers. Image G: Copper dot map with red dots scattered on black. Scale bar: 2 micrometers. Image H: Iron dot map with green dots and dense clusters on black. Scale bar: 2 micrometers. Image I: Phosphorus dot map with purple dots and clusters on black. Scale bar: 2 micrometers. Synthesis and Characterizations of the Schottky Junction Semiconductor Nanocatalysts MnFe2O4/ TiVNbMoC3. (A) SEM image of MnFe2O4/TiVNbMoC3 composite material. MnFe2O4 adhere to the surface of TiVNbMoC3 lamellar layers, manifesting as clusters of aggregated particles due to its magnetic properties. (B) TEM image of the composite of TiVNbMoC3 monolayer and MnFe2O4 nanoparticles. The dark areas in the image represent MnFe2O4, which is clearly bound to the surface of the TiVNbMoC3 monolayer, indicating successful synthesis of the composite material. The distribution of Mn (dark green) and Fe (light green) elements closely overlaps, confirming the formation of MnFe2O4. The distribution of oxygen (pink) is somewhat correlated with that of Mn and Fe, but it is also present in other regions, potentially indicating partial oxidation on the sample surface. Energy-dispersive X-ray spectroscopy (EDX) verified the elemental composition (Figure 3). A representative EDX spectrum of the material was shown. Peaks corresponding to the constituent elements of TiVNbMoC3MXene (Ti, V, Nb, Mo, C) alongside Fe from MnFe2O4 are clearly detected. The C-K and O-K peaks appear in the low-energy region (<1 keV), while the Ti-K, V-K, Fe-K, and a potential Cu-K peak (possibly from the sample holder) are located at approximately 4.5 keV, 5 keV, 6.4 keV, and 8 keV, respectively. The Mn peak remains unidentified, likely due to its weak signal or overlap with neighboring peaks. The oxygen content may originate from both the MnFe2O4 lattice and potential surface oxidation. The pronounced carbon peak stems primarily from the MXene backbone. No significant impurity peaks were detected, supporting the successful synthesis of the target composite.Figure 3Energy-dispersive X-ray spectroscopy (EDX) elemental analysis of the MnFe2O4 /TiVNbMoC3 nanocomposite.A spectrum plot of elemental peaks versus energy, with a dominant low-energy peak and several mid-energy peaks.Energy-dispersive X-ray spectroscopy (EDX) analysis of MnFeO/TiVNbMoC nanocomposite shows a spectrum with energy (keV) from 0 to 14 and intensity (Y cps/eV) from 0 to 9. Peaks are concentrated between 0 and 2.5 keV, with C-K and O-K peaks on the left and Nb, Mo, Ti, V, Fe and Cu peaks in the low-energy region. A prominent Mo-La peak reaches 9 Y cps/eV near 2 keV. In the mid-energy region, Ti peaks at 4.5 keV with 4 Y cps/eV, V-Ka peaks at 5 keV with 4.5 Y cps/eV, Fe-Ka peaks at 6.4 keV with 4 Y cps/eV and Cu-Ka peaks at 8 keV with 4 Y cps/eV. A smaller peak near 9 keV is below 1 Y cps/eV. From 10 to 14 keV, the trace remains near 0. Energy-dispersive X-ray spectroscopy (EDX) elemental analysis of the MnFe2O4 /TiVNbMoC3 nanocomposite. The crystalline structure was analyzed by X-ray diffraction (XRD) (Figure 4). The diffraction pattern of TiVNbMoC3 showed characteristic peaks at 2θ ≈ 36°, 41°, and 74°. New peaks emerging at approximately 30°, 35°, and 62° correspond to the characteristic reflections of MnFe2O4, confirming its successful incorporation into the composite.Figure 4XRD reveals the primary diffraction peaks of the TiVNbMoC3 (A) and MnFe2O4 /TiVNbMoC3 (B).Two X-ray diffraction line plots comparing TiVNbMoC3 and MnFe2O4 over TiVNbMoC3 peak patterns. XRD reveals the primary diffraction peaks of the TiVNbMoC3 (A) and MnFe2O4 /TiVNbMoC3 (B). Dynamic light scattering (DLS) indicated an average hydrodynamic diameter of approximately 165 nm (Figure 5A), consistent with TEM observations. The material exhibited a zeta potential of −27.9 mV (Figure 5B), confirming good colloidal stability in aqueous dispersion. This stability was further corroborated by a distinct Tyndall effect (Figure 6), where a laser beam passed through the dispersion produced a visible light-scattering path, characteristic of a stable colloid.Figure 5Hydrodynamic diameter and zeta potential characterization of the MnFe2O4/ TiVNb MoC3 -RGD nanocomposite. (A) Size distribution profile measured by dynamic light scattering (DLS). The peak indicates an average hydrodynamic diameter of approximately 165 nm (A). (B) Zeta potential measurement (B). The average zeta potential of the material in PBS buffer was −27.9 mV, indicating a negatively charged surface and confirming good colloidal stability.A histogram and line plot showing size distribution and zeta potential of MnFe2O4 slash TiVNbMoC3.Image A shows a histogram with a line labeled MnFe2O4/TiVNbMoC3. The x-axis is Size (d.nm) ranging from 0 to 300 and the y-axis is Volume (%) ranging from 0 to 35. Bars extend from 100 to 260 on the x-axis. The tallest bar is between 160-180 nm at 28%. Other bars: 100-120 nm at 2%, 120-140 nm at 12%, 140-160 nm at 24%, 180-200 nm at 21%, 200-230 nm at 10% and 230-260 nm at 2%. The curve peaks near 170 nm at 28%. Image B shows a histogram with a line labeled MnFe2O4/TiVNbMoC3. The x-axis is Zeta potential (mV) from -60 to 20 and the y-axis is Intensity (a.u.) from 0 to 35. Bars span from -50 to 0 mV, with the tallest between -30 and -20 mV. The curve peaks near -25 mV at 33-35%.Figure 6Tyndall effect.Two images of a colloidal dispersion, one with a visible Tyndall effect. Hydrodynamic diameter and zeta potential characterization of the MnFe2O4/ TiVNb MoC3 -RGD nanocomposite. (A) Size distribution profile measured by dynamic light scattering (DLS). The peak indicates an average hydrodynamic diameter of approximately 165 nm (A). (B) Zeta potential measurement (B). The average zeta potential of the material in PBS buffer was −27.9 mV, indicating a negatively charged surface and confirming good colloidal stability. Tyndall effect. Surface chemical states were investigated by X-ray photoelectron spectroscopy (XPS). The survey scan spectrum of the material showed all detected elements (Figure 7A). (B-I) High- resolution XPS spectra of C 1s (Figure 7B), Fe 2p (Figure 7C), Mo3d (Figure 7D), Nb 3d (Figure 7E), V 2p (Figure 7F), O1s (Figure 7G) and Mn 2p (Figure 7H) and Ti 2p (Figure 7I) regions. The high-resolution spectra revealed the following: C 1s: Deconvoluted into C–C (284.8 eV), C–O, and C=O bonds. Fe 2p: The Fe 2p peak at ~711 eV is indicative of Fe3⁺, consistent with its state in MnFe2O4.Nb 3d: The Nb 3d5/peak at ~207 eV suggests a high oxidation state (Nb).V 2p: The V 2p3/peak position (~516–517 eV) corresponds to V or V.O 1s: Comprised contributions from lattice oxygen (~530 eV) and surface-adsorbed oxygen/hydroxyl groups (~531–532 eV). Mn 2p: The characteristic doublet indicates the presence of mixed Mn2+⁺and Mn3 +oxidation states. Ti 2p: The Ti 2p/ peak at ~458–459 eV confirms Ti exists primarily as Ti.4⁺Figure 7X-ray photoelectron spectroscopy (XPS) characterization and surface chemical state analysis of the MnFe2O4/ TiVNbMoC3 -RGD nanocomposite. The survey scan spectrum of the material showed all detected elements (A). (B–I) High- resolution XPS spectra of C 1s (B), Fe 2p (C), Mo3d (D), Nb 3d (E), V 2p (F), O1s (G) and Mn 2p (H) and Ti 2p (I) regions.Nine X-ray photoelectron spectroscopy plots of survey and core-level fits for MnFe2O4 TiVNbMoC3.A 3 by 3 set of line plots for X-ray photoelectron spectroscopy. In all plots, the x-axis is Binding energy (eV) and the y-axis is Intensity (a.u.). The image A showing a survey scan labeled MnFe2O4/TiVNbMoC3. X-axis ranges 1200 to 0 eV. Labeled peaks: O 1s near 530 eV, Fe 2p near 710 eV, Mn 2p near 640 eV, V 2p near 515 eV, Ti 2p near 460 eV, C 1s near 285 eV, Mo 3d near 232 eV, Nb 3d near 207 eV. The image B showing C 1s. X-axis 295 to 280 eV. A measured jagged trace with multiple fitted component curves and a total-fit curve; dominant peak at about 285 eV, smaller components around 286 to 289 eV. The image C showing Fe 2p. X-axis 740 to 705 eV. Measured trace plus background and fitted components; main peaks around 724 to 725 eV and 710 to 711 eV. The image D showing Mo 3d. X-axis 242 to 226 eV. Two strong peaks near 235 eV and 232 eV, with smaller fitted features near 229 to 230 eV. The image E showing Nb 3d. X-axis 214 to 200 eV. Peaks near 210 eV and 207 eV, plus a smaller peak near 203 eV. The image F showing V 2p. X-axis 540 to 510 eV. A strong peak near 530 eV and a smaller peak near 525 to 526 eV, with fitted components and a total-fit curve. The image G showing O 1s. X-axis 540 to 526 eV. Main peak near 530 to 531 eV with additional fitted components near 532 to 534 eV. The image H showing Mn 2p. X-axis 660 to 635 eV. Broad features with peaks around 653 to 655 eV and 641 to 645 eV, with background and fitted components. The image I showing Ti 2p. X-axis 470 to 450 eV. A main peak near 458 to 459 eV, additional features near 464 to 466 eV and smaller peaks near 454 to 456 eV. Overall, the survey scan labels confirm the presence of the listed elements and the core-level plots show measured spectra decomposed into background, component peaks and a total fit. X-ray photoelectron spectroscopy (XPS) characterization and surface chemical state analysis of the MnFe2O4/ TiVNbMoC3 -RGD nanocomposite. The survey scan spectrum of the material showed all detected elements (A). (B–I) High- resolution XPS spectra of C 1s (B), Fe 2p (C), Mo3d (D), Nb 3d (E), V 2p (F), O1s (G) and Mn 2p (H) and Ti 2p (I) regions. Optical and Functional Properties UV–vis spectroscopy was used to evaluate optical absorption (Figure 8). The MnFe2O4/TiVNbMoC3 composite exhibited broad absorption from 300 to 800 nm. Compared to pure TiVNbMoC3, the UV absorption intensity of the composite decreased, but it showed significantly enhanced absorption in the visible to near - infrared region (400–800 nm) due to the incorporation of MnFe2O4.Figure 8Optical absorption properties of the nanocomposite.A line graph comparing ultraviolet to visible absorbance spectra for TiVNbMoC3 and MnFe2O4 slash TiVNbMoC3. Optical absorption properties of the nanocomposite. The reactive oxygen species (ROS) generation capability was assessed with 1,3-diphenylisobenzofuran (DPBF) as a probe. Under light irradiation, the characteristic absorption of DPBF at 410 nm decreased progressively over time for the composite dispersion, indicating continuous ROS production. In contrast, no significant change was observed in the PBS control (Figure 9).Figure 9ROS generation capacity of the nanocomposite under 808 nm laser irradiation measured using the DPBF probe method. Time-dependent decrease (0–7 min) in the characteristic absorbance of DPBF at 410 nm, indicating the ROS generation kinetics of the MnFe2O4/ TiVNbMoC3 -RGD composite (100 µg/mL) and control groups under 808 nm laser irradiation (1 W/cm2).A line graph showing absorbance versus wavelength for eight time points from 0 minute to 7 minute. ROS generation capacity of the nanocomposite under 808 nm laser irradiation measured using the DPBF probe method. Time-dependent decrease (0–7 min) in the characteristic absorbance of DPBF at 410 nm, indicating the ROS generation kinetics of the MnFe2O4/ TiVNbMoC3 -RGD composite (100 µg/mL) and control groups under 808 nm laser irradiation (1 W/cm2). The photothermal performance was evaluated under 808 nm NIR laser irradiation (Figure 10). An aqueous dispersion of the nanocomposite exhibited a rapid temperature increase, reaching approximately 42 °C within 25 minutes, significantly higher than the minimal temperature change observed for pure water. This demonstrates the material’s effective photothermal conversion capability.Figure 10Photothermal performance of the nanocomposite aqueous dispersion under 808 nm NIR laser irradiation. Representative infrared thermal images of pure water (Control) and the MnFe2O4/ TiVNbMoC3 -RGD nanocomposite dispersion (100 µg/mL) under 808 nm laser irradiation (1.0 W/cm2) for different durations (0, 5, 10, 15, 20, 25min).Six infrared heatmaps of two samples, with temperature labels in degrees Celsius for each sample.Six infrared heatmaps display two circular samples each, marked with crosshairs and temperature labels in Celsius. A thermal gradient indicates cooler tones for lower temperatures and warmer tones for higher temperatures, without a legend. Heatmap 1: left sample 26.2°C, right sample 26.5°C, additional label 29.0°C. Heatmap 2: left 33.8°C, right 31.4°C. Heatmap 3: left 38.7°C, right 36.0°C. Heatmap 4: left 41.8°C, right 38.7°C. Heatmap 5: left 40.0°C, right 35.9°C. Heatmap 6: left 42.0°C, right 37.5°C. Across all heatmaps, temperatures increase from mid-20s to low-40s°C, with the left sample consistently warmer than the right from heatmap 2 to 6. Photothermal performance of the nanocomposite aqueous dispersion under 808 nm NIR laser irradiation. Representative infrared thermal images of pure water (Control) and the MnFe2O4/ TiVNbMoC3 -RGD nanocomposite dispersion (100 µg/mL) under 808 nm laser irradiation (1.0 W/cm2) for different durations (0, 5, 10, 15, 20, 25min). In vitro Cellular Assays Cellular Uptake and Localization Over time, the red fluorescence (Cy5.5) gradually increased from nearly undetectable at 0 h to markedly enhanced at 12 h, indicating time‑dependent accumulation of the material inside the cells. The green fluorescence (DiO) remained relatively stable throughout the process, clearly delineating the cell membrane structure. The blue fluorescence (DAPI) showed that the nucleus position remained largely unchanged. In the merged images, an increasing colocalization of red and green fluorescence was observed over time, suggesting progressive internalization of the material by the cells. These results demonstrate that the nanocomposite is efficiently taken up by bladder cancer cells in a time‑dependent manner, supporting its potential for therapeutic applications. The cellular internalization of the Cy5.5-labeled MnFe2O4/TiVNbMoC3-RGD nanocomposite was tracked over time using confocal microscopy (Figure 11). The red fluorescence signal (Cy5.5) was nearly undetectable at 0 h and then increased progressively, indicating continuous cellular accumulation. At 12 h, a strong intracellular signal was observed, which showed significant co-localization (yellow) with the DiO-labeled cell membrane (green), confirming effective and time-dependent cellular uptake and internalization. Nuclear morphology, stained with DAPI (blue), remained unchanged.Figure 11This fluorescence confocal image shows the cellular uptake of the MnFe2O4/ TiVNbMoC3 -cRGD material at different time points (0, 2, 4, 8, and 12 h). The image is organized into four rows: Cy5.5 (red fluorescence) indicates the distribution of the material within the cells; DiO (green fluorescence) labels the cell membrane; DAPI (blue fluorescence) stains the cell nucleus; and the merged images combine all three channels.20-image grid: Cy5.5, DiO, DAPI, merged channels at 0, 2, 4, 8, 12 h on black background.The image showing a composite fluorescence microscopy figure arranged as a 4 by 5 grid on a black background, with five time-point columns and four fluorescence-channel rows. The column titles across the top read 0 h, 2 h, 4 h, 8 h and 12 h. The row labels along the left margin read Cy5.5, DiO, DAPI and Merged. Each tile contains a small white scale bar at the lower right labeled 20 µm. The image showing the Cy5.5 row (top row) with five red-channel micrographs. At 0 h, the tile contains a black field with no red structures. At 2 h, multiple red cell-shaped outlines and clusters occupy the central and upper regions, with scattered red fragments around them. At 4 h, fewer red cell-shaped structures are present, separated into smaller groups with larger black gaps between groups. At 8 h, larger red connected regions form elongated and branching cell-shaped networks spanning the center and right side. At 12 h, dense red connected cell-shaped regions occupy much of the tile, with many adjacent red outlines forming a broad network. The image showing the DiO row (second row) with five green-channel micrographs. At 0 h, green cell-shaped outlines and clusters occupy the left and central regions, with several isolated green shapes toward the right. At 2 h, numerous green cell-shaped structures and clusters are distributed across most of the tile, forming many adjacent outlines. At 4 h, green structures are fewer and more separated, with several clusters concentrated near the center and upper portions. At 8 h, green signal forms larger connected cell-shaped regions, including elongated structures extending across the center. At 12 h, widespread green cell-shaped regions and clusters occupy much of the tile, with multiple connected outlines across the field. The image showing the DAPI row (third row) with five blue-channel micrographs consisting of discrete oval and round nuclear-shaped signals. At 0 h, a compact cluster of blue nuclei occupies the left-central area, with a few nuclei scattered nearby. At 2 h, many blue nuclei are distributed broadly across the tile, forming multiple clusters and scattered single nuclei. At 4 h, fewer blue nuclei are present, separated into small groups with larger black spaces between groups. At 8 h, blue nuclei form several clusters distributed across the tile, including groups near the center and right. At 12 h, many blue nuclei are distributed across the tile, with clusters and scattered nuclei spanning left to right. The image showing the Merged row (bottom row) with five multicolor overlays combining red, green and blue signals. At 0 h, green cell-shaped outlines contain multiple blue nuclei, with minimal red contribution. At 2 h, extensive overlap of red and green signals forms multicolored cell-shaped regions across the tile, with blue nuclei positioned within many of these regions. At 4 h, merged signals occur in fewer separated cell groups, with red and green outlines surrounding blue nuclei in several clusters. At 8 h, large connected multicolored regions span the center and right, with red and green overlap forming bright composite areas and blue nuclei distributed within these connected regions. At 12 h, dense multicolored connected regions occupy much of the tile, with widespread red and green overlap and numerous blue nuclei embedded throughout the clustered structures. This fluorescence confocal image shows the cellular uptake of the MnFe2O4/ TiVNbMoC3 -cRGD material at different time points (0, 2, 4, 8, and 12 h). The image is organized into four rows: Cy5.5 (red fluorescence) indicates the distribution of the material within the cells; DiO (green fluorescence) labels the cell membrane; DAPI (blue fluorescence) stains the cell nucleus; and the merged images combine all three channels. Antiproliferative Effects The impact on cell viability and long-term proliferation was assessed. The CCK-8 assay was performed to evaluate the effects of three materials (TiVNbMoC3, MnFe2O4/TiVNbMoC3, and MnFe2O4/TiVNbMoC3-RGD) on the viability of 5637 bladder cancer cells, which revealed a dose - dependent decrease in cell viability. (Figure 12). While all materials showed comparable effects at lower concentrations (≤25 µg/mL), MnFe2O4-containing composites exhibited significantly enhanced cytotoxicity at higher doses. At 100 µg/mL, cell viability was reduced to ~10% for both MnFe2O4 composites, compared to ~40% for TiVNbMoC3 alone.Figure 12Effects of various nanomaterials on the viability of bladder cancer cells assessed by CCK-8 assay. Cell viability of 5637 cells measured by CCK-8 assay after 48 h treatment (detailed method in Methods 2.2) Data are mean ± SD (n=3). p < 0.001 vs control.A grouped bar graph showing 5637 cell viability across concentration for three nanomaterials. Effects of various nanomaterials on the viability of bladder cancer cells assessed by CCK-8 assay. Cell viability of 5637 cells measured by CCK-8 assay after 48 h treatment (detailed method in Methods 2.2) Data are mean ± SD (n=3). p < 0.001 vs control. Additionally, the colony formation assay was carried out to assess the clonogenic capacity of these cells. The colony formation assay further corroborated the superior long-term anti -proliferative effect of the MnFe2O4/TiVNbMoC3-RGD nanocomposite (Figure 13). Quantitative analysis showed the average number of colonies decreased from ~160 (control) to 120 (TiVNbMoC3), 70 (doxorubicin, DOX), and only 40 for the MnFe2O4/TiVNbMoC3-RGD group, demonstrating its potent suppression of clonogenic survival.Figure 13Colony formation assay evaluating the effect of (MnFe2O4/TiVNbMoC3 -RGD) on the clonogenicity of bladder cancer cells. (A) Representative images of colonies formed by 5637 cells after treatment with (MnFe2O4/TiVNbMoC3 -RGD at 25 ug/mL. (B) Statistical analysis of colony numbers. Data are presented as mean ± SD, n=3;**p < 0.01, ***p < 0.001 vs Control group.A mixed figure showing four colony images and one bar chart of colony numbers for 5637 cells.The image A showing four circular colony formation assay dishes labeled Control, TiVNbMoC subscript 3, DOX and MnFe subscript 2 O subscript 4 slash TiVNbMoC subscript 3 dash RGD. A vertical label at left reads 5637. The Control dish shows the densest field of colonies, TiVNbMoC subscript 3 shows fewer, DOX shows fewer again and MnFe subscript 2 O subscript 4 slash TiVNbMoC subscript 3 dash RGD shows the sparsest colonies. The image B showing a bar chart with x-axis label 5637 and y-axis label Colony numbers with range 0 to 200. Four bars correspond to Control, TiVNbMoC subscript 3, DOX and MnFe subscript 2 O subscript 4 slash TiVNbMoC subscript 3 dash RGD. Approximate bar heights are: Control about 160, TiVNbMoC subscript 3 about 120, DOX about 70 and MnFe subscript 2 O subscript 4 slash TiVNbMoC subscript 3 dash RGD about 40. Each bar includes small point markers near the bar top. Significance brackets above the bars show double asterisk and triple asterisk annotations. Colony formation assay evaluating the effect of (MnFe2O4/TiVNbMoC3 -RGD) on the clonogenicity of bladder cancer cells. (A) Representative images of colonies formed by 5637 cells after treatment with (MnFe2O4/TiVNbMoC3 -RGD at 25 ug/mL. (B) Statistical analysis of colony numbers. Data are presented as mean ± SD, n=3;**p < 0.01, ***p < 0.001 vs Control group. Inhibition of Cell Migration A scratch wound healing assay evaluated the effect on cell migration (Figure 14). After 48 h, control cells achieved ~95% wound closure. Migration was slightly inhibited by TiVNbMoC3 (~80% closure) and more substantially by DOX (~50% closure). Notably, treatment with MnFe2O4/TiVNbMoC3-RGD strongly suppressed migration, resulting in only ~20% wound closure, indicating its potent anti-migratory activity.Figure 14Effects of nanomaterials on the migration ability of bladder cancer cells assessed by scratch wound healing assay. (A) Representative microscope images showing wound healing at 0 h and 48 h for 5637 bladder cancer cells treated with PBS (Control), TiVNbMoC3, DOX, and, MnFe2O4/TiVNbMoC3, and MnFe2O4/TiVNbMoC3 -RGD (25 ug/mL) for 48 h. Scale bar: 200 um. (B) Statistical analysis of wound healing rates calculated from the images. Data are presented as mean ± SD (n=3); **p < 0.01,***p < 0.001 vs Control group.Microscope images and graph showing wound healing in 5637 cells treated with various substances over time.The image A shows microscope images of 5637 bladder cancer cells at 0 h, 24 h and 48 h under different treatments: Control, TiVNbMoC subscript 3, DOX and MnFe subscript 2 O subscript 4/TiVNbMoC subscript 3-rGD. The images depict the progression of wound healing over time. The image B shows a bar graph illustrating the wound healing rate in percentage over time (24 h and 48 h) for the same treatments. The x-axis is labeled 'Time (h)' and the y-axis is labeled 'Wound healing Rate (%)'. Statistical significance is indicated with asterisks: p < 0.01, *p < 0.001. The treatments are color-coded: Control, TiVNbMoC subscript 3, DOX and MnFe subscript 2 O subscript 4/TiVNbMoC subscript 3-rGD. Effects of nanomaterials on the migration ability of bladder cancer cells assessed by scratch wound healing assay. (A) Representative microscope images showing wound healing at 0 h and 48 h for 5637 bladder cancer cells treated with PBS (Control), TiVNbMoC3, DOX, and, MnFe2O4/TiVNbMoC3, and MnFe2O4/TiVNbMoC3 -RGD (25 ug/mL) for 48 h. Scale bar: 200 um. (B) Statistical analysis of wound healing rates calculated from the images. Data are presented as mean ± SD (n=3); **p < 0.01,***p < 0.001 vs Control group. Induction of Cell Death and Apoptosis Calcein AM/PI staining visualized live/dead cells (Figure 15). A clear gradient of increasing cytotoxicity was observed: control cells showed dense green fluorescence (live), which moderately decreased in the TiVNbMoC3 and DOX groups with emerging red fluorescence (dead). The MnFe2O4/ TiVNbMoC3-cRGD group exhibited the most pronounced cytotoxicity, with the weakest green and strongest red fluorescence, indicating favorable cell-killing efficacy over DOX.Figure 15Cytotoxic effect of nanomaterials on bladder cancer cells evaluated by Calcein AM/PI double staining. Representative fluorescence images of 5637 bladder cancer cells after treatment with PBS (Control), TiVNbMoC3, DOX, and MnFe2O4/TiVNbMoC3 -RGD (50 μg/mL) for 48 h. Live cells are stained green with Calcein AM, and dead cell nuclei are stained red with propidium iodide (PI). Scale bar: 100 μm.Fluorescence grid: green/red puncta on black, 12 tiles labeled Control, TiVNbMoC3, DOX, MnFe2O4/TiVNbMoC3-rGD.The images depict fluorescence micrographs under different conditions. Images A and B show the AM row with numerous green puncta on a black background, while images C and D show fewer green puncta. Images E and F display the PI row with sparse red puncta, whereas images G and H have numerous red puncta. The Merged row in images I and J shows many green and few red puncta, while images K and L contain both green and numerous red puncta. The columns are labeled Control, TiVNbMoC3, DOX and MnFe2O4/TiVNbMoC3-rGD, with rows labeled AM (green), PI (red) and Merged (black). Cytotoxic effect of nanomaterials on bladder cancer cells evaluated by Calcein AM/PI double staining. Representative fluorescence images of 5637 bladder cancer cells after treatment with PBS (Control), TiVNbMoC3, DOX, and MnFe2O4/TiVNbMoC3 -RGD (50 μg/mL) for 48 h. Live cells are stained green with Calcein AM, and dead cell nuclei are stained red with propidium iodide (PI). Scale bar: 100 μm. Flow cytometry analysis using Annexin V-FITC/PI staining quantified apoptosis. Both control and TiVNbMoC3 groups showed low background apoptosis (<10%). DOX induced moderate apoptosis (~13%) (Figure 16A). In contrast, MnFe2O4/TiVNbMoC3-RGD group triggered the highest level of apoptosis, reaching ~42%, confirming its potent pro-apoptotic effect (Figure 16B).Figure 16Analysis of cell apoptosis by flow cytometry using Annexin V-APC/PI staining.(A) Representative flow cytometry scatter plots showing apoptosis of 5637 bladder cancer cells treated with PBS (Control), TiVNbMoC3, DOX, and MnFe2O4/ TiVNbMoC3-cRGD (25 µg/mL) for 48 h. The lower left quadrant (Annexin V−/PI−) represents live cells, lower right quadrant (Annexin V+/PI−) early apoptotic cells, and upper right quadrant (Annexin V+/PI+) late apoptotic/ necrotic cells.(B) Quantitative analysis of total apoptotic cells (early + late) from three independent experiments. The control and TiVNbMoC3 groups showed low background apoptosis (<10%). DOX induced moderate apoptosis (~13%). The MnFe2O4/ TiVNbMoC3-cRGD nano -composite triggered the highest level of apoptosis (~42%), indicating its potent pro-apoptotic effect. Data are presented as mean ± SD (n = 3). ns (not significant) indicates no statistically significant difference between the indicated groups (eg, Control vs TiVNbMoC3),***p < 0.001 indicates a statistically significant difference compared to the control group (one way ANOVA with Tukey’s post‑hoc test).An infographic of flow cytometry and bar chart showing highest apoptosis with MnFe2O4/TiVNbMoC3-rGD.Image A displays a 2x2 grid of flow cytometry scatter plots labeled Control, TiVNbMoC3, DOX and MnFe2O4/TiVNbMoC3-rGD. Axes are Annexin V-FITC (x) and PI (y). Quadrant values: Control - Q1: 19.2, Q2: 2.50, Q3: 1.70, Q4: 76.6; TiVNbMoC3 - Q1: 17.8, Q2: 2.99, Q3: 1.60, Q4: 77.5; DOX - Q1: 40.9, Q2: 16.1, Q3: 12.1, Q4: 31.0; MnFe2O4/TiVNbMoC3-rGD - Q1: 32.1, Q2: 19.4, Q3: 10.4, Q4: 38.1. Image B features a bar chart of apoptotic cells (%) with y-axis ticks at 0, 5, 10, 15, 20. Bars represent Control, TiVNbMoC3, DOX and MnFe2O4/TiVNbMoC3-rGD, with dot markers. Control and TiVNbMoC3 bars are near 2%, DOX near 12-13%, MnFe2O4/TiVNbMoC3-rGD near 15%. Significance labels: 'ns' for Control vs TiVNbMoC3, '***' for DOX and MnFe2O4/TiVNbMoC3-rGD comparisons. Analysis of cell apoptosis by flow cytometry using Annexin V-APC/PI staining.(A) Representative flow cytometry scatter plots showing apoptosis of 5637 bladder cancer cells treated with PBS (Control), TiVNbMoC3, DOX, and MnFe2O4/ TiVNbMoC3-cRGD (25 µg/mL) for 48 h. The lower left quadrant (Annexin V−/PI−) represents live cells, lower right quadrant (Annexin V+/PI−) early apoptotic cells, and upper right quadrant (Annexin V+/PI+) late apoptotic/ necrotic cells.(B) Quantitative analysis of total apoptotic cells (early + late) from three independent experiments. The control and TiVNbMoC3 groups showed low background apoptosis (<10%). DOX induced moderate apoptosis (~13%). The MnFe2O4/ TiVNbMoC3-cRGD nano -composite triggered the highest level of apoptosis (~42%), indicating its potent pro-apoptotic effect. Data are presented as mean ± SD (n = 3). ns (not significant) indicates no statistically significant difference between the indicated groups (eg, Control vs TiVNbMoC3),***p < 0.001 indicates a statistically significant difference compared to the control group (one way ANOVA with Tukey’s post‑hoc test). Induction of Immunogenic Cell Death (ICD) Western blot analysis was performed to assess key ICD markers (Figure 17). Compared to the control, HMGB1 and calreticulin (CRT) expression was slightly elevated in the TiVNbMoC3 group and significantly upregulated by DOX. The MnFe2O4/TiVNbMoC3-cRGD nanocomposite induced the most substantial increase in both proteins, particularly CRT. Equivalent GAPDH levels confirmed consistent loading. These results demonstrate the nanocomposite’s efficacy in inducing ICD, characterized by robust CRT exposure and HMGB1 release.Figure 17Western blot analysis shows the effect of different treatment groups on the expression of immunogenic cell death markers in bladder cancer cells.Western blot showing CRT, HMGB1 and GAPDH expression in different treatment groups. Western blot analysis shows the effect of different treatment groups on the expression of immunogenic cell death markers in bladder cancer cells. In vivo Antitumor Efficacy The nanocomposites demonstrated favorable antitumor effects in a bladder cancer xenograft model (Figure 18). Moreover, it exhibited the most potent tumor growth inhibition, with final tumor volume reduced to approximately 1/3 of the control group (p < 0.001; Figures 19 and 20), significantly outperforming DOX.Figure 18Schematic illustration of tumor therapeutic protocols.Timeline of tumor treatment in mice with laser and NP injections.Figure 19(A) Bladder xenograft tumor mouse models of different groups and (B) Statistical analysis of tumor growth curves measured after 14 days of treatment. Data are presented as mean ± SD (n=5),***p < 0.001 vs Control group.Four mouse photos and a line graph of tumor volume over time for four treatment groups.Image A displays four mouse photos with tumors marked by dashed circles, labeled: Control, TiVNbMoC3, DOX, MnFe2O4 TiVNbMoC3 rGD. Image B features a line graph titled '5637 cell line' with growth curves and significance marked by asterisks. The x-axis is Time (Days), from 5 to 30 and the y-axis is Tumor volume (mm³), from 0 to 1500. Legend: Control, TiVNbMoC3, DOX, MnFe2O4 TiVNbMoC3 rGD. Approximate values: Control: (5, 80), (10, 120), (15, 250), (20, 450), (25, 750), (30, 1100). TiVNbMoC3: (5, 70), (10, 110), (15, 220), (20, 380), (25, 600), (30, 850). DOX: (5, 60), (10, 90), (15, 170), (20, 280), (25, 420), (30, 600). MnFe2O4 TiVNbMoC3 rGD: (5, 50), (10, 80), (15, 130), (20, 200), (25, 300), (30, 380).Figure 20Inhibitory effects on tumor growth by different drug treatment groups. (A) Tumor volume curves over time in mice treated with PBS (Control), TiVNbMoC3, DOX, and MnFe2O4/ TiVNbMoC3-cRGD (25 µg/mL) for 14 days. (B) Representative photographs of excised tumors at the end of treatment. Statistical analysis of tumor weights. Data are presented as mean ± SD (n=5); ***p < 0.001 vs Control group.Two-part figure with tumor photos and a bar chart of tumor weight by treatment group.The image A showing a photograph of excised tumors arranged in four horizontal rows, with group labels at the right: Control, TiVNbMoC subscript 3, DOX and MnFe subscript 2 O subscript 4 slash TiVNbMoC subscript 3 dash rGD. Each row contains five tumors. A ruler at the bottom is labeled 0 centimeter through 8 centimeter. The image B showing a bar chart with y-axis label Tumor weight left parenthesis g right parenthesis and y-axis range 0.0 to 1.5. The x-axis categories are Control, TiVNbMoC subscript 3, DOX and MnFe subscript 2 O subscript 4 slash TiVNbMoC subscript 3 dash rGD. Bar heights are approximately: Control 1.0, TiVNbMoC subscript 3 0.75, DOX 0.50, MnFe subscript 2 O subscript 4 slash TiVNbMoC subscript 3 dash rGD 0.15. Each bar has five dot markers. Three horizontal significance brackets labeled asterisk asterisk asterisk compare Control to TiVNbMoC subscript 3, Control to DOX and Control to MnFe subscript 2 O subscript 4 slash TiVNbMoC subscript 3 dash rGD. Schematic illustration of tumor therapeutic protocols. (A) Bladder xenograft tumor mouse models of different groups and (B) Statistical analysis of tumor growth curves measured after 14 days of treatment. Data are presented as mean ± SD (n=5),***p < 0.001 vs Control group. Inhibitory effects on tumor growth by different drug treatment groups. (A) Tumor volume curves over time in mice treated with PBS (Control), TiVNbMoC3, DOX, and MnFe2O4/ TiVNbMoC3-cRGD (25 µg/mL) for 14 days. (B) Representative photographs of excised tumors at the end of treatment. Statistical analysis of tumor weights. Data are presented as mean ± SD (n=5); ***p < 0.001 vs Control group. Histopathological and Immunohistochemical Analysis Tumor tissue analysis further validated the therapeutic outcome. TUNEL staining revealed a marked increase in apoptotic cells in the nanocomposite-treated group compared to all controls (Figure 21). Immunofluorescence for Ki-67 showed a significant reduction in proliferating cells, and this reduction was supported by a decreased nuclear-cytoplasmic ratio in DAPI-stained sections (Figure 22). H&E staining confirmed the most substantial tumor tissue damage -including structural disruption, vacuolation, and necrosis—following nanocomposite treatment (Figure 23).Figure 21Analysis of nanomaterial-induced apoptosis in tumor tissues via TUNEL assay Schematic of the staining protocol: after deparaffinization and permeabilization, DNA strand breaks were labeled (red, 520 nm) and nuclei were counterstained with DAPI (blue, 460 nm).Fluorescence grid: red TUNEL, blue DAPI, merged stains, 4 groups, black background, 20μm scale bar.Image is a composite fluorescence microscopy figure with a 4x3 grid of micrographs on a white background. Columns are TUNEL (red), DAPI (blue) and Merged (black). Rows are Control, TiVNbMoC3, DOX and MnFe2O4 TiVNbMoC3 rGD. Each micrograph has a black background and a 20 micrometer scale bar. Control: TUNEL shows sparse red puncta and larger spots. DAPI displays many small blue nuclear dots. Merged combines blue dots with scattered red puncta. TiVNbMoC3: TUNEL has more red puncta and brighter clusters. DAPI shows a dense field of blue dots. Merged overlays red puncta on the blue field. DOX: TUNEL contains frequent red puncta and clusters. DAPI has a dense blue nuclear field. Merged overlays red puncta on the blue field. MnFe2O4 TiVNbMoC3 rGD: TUNEL shows numerous red puncta and clusters. DAPI has a dense blue nuclear field. Merged overlays red puncta on the blue field.Figure 22Assessment of tumor cell proliferation by Ki-67 immunofluorescence staining.Fluorescence micrograph: green Ki-67, blue DAPI, merged channels, 4 labeled groups on dark background.The fluorescence microscopy layout features four rows and three columns on a white background. Columns are labeled Ki-67 (green), DAPI (blue) and Merged (black). Rows include Control, TiVNbMoC3, DOX and MnFe2O4 TiVNbMoC3 rGD.- Control: - Ki-67: Dark field, many small green signals. - DAPI: Dark field, numerous blue signals. - Merged: Green and blue overlay.- TiVNbMoC3: - Ki-67: Sparse, clustered green signals. - DAPI: Blue signals spread across. - Merged: Green and blue overlay.- DOX: - Ki-67: Scattered green, bright clusters. - DAPI: Many blue signals. - Merged: Green and blue overlay. - MnFe2O4 TiVNbMoC3 rGD: - Ki-67: Scattered green, bright clusters. - DAPI: Blue signals throughout. - Merged: Green and blue overlay.Each image has a white scale bar at the lower right.Figure 23H&E staining for histopathological analysis.Micrograph: 4 stained sections (Control, TiVNbMoC3, DOX, MnFe2O4 TiVNbMoC3 rGD) with 100μm scale bar. Analysis of nanomaterial-induced apoptosis in tumor tissues via TUNEL assay Schematic of the staining protocol: after deparaffinization and permeabilization, DNA strand breaks were labeled (red, 520 nm) and nuclei were counterstained with DAPI (blue, 460 nm). Assessment of tumor cell proliferation by Ki-67 immunofluorescence staining. H&E staining for histopathological analysis. Biosafety and Biocompatibility Assessment A hemolysis assay indicated concentration-dependent effects, with negligible hemolysis (<5%) at concentrations below 50 µg/mL and a critical threshold near 100 µg/mL (Figure 24). Histopathological examination of major organs (heart, liver, spleen, lungs, kidneys) from treated mice showed no obvious lesions or damage compared to controls, confirming the appreciable in vivo biocompatibility of the nanocomposite (Figure 25).Figure 24Different concentrations of nanomaterials in hemolysis assay.Seven test tubes with varying concentrations of nanomaterials.Figure 25Histological analysis of major organs of healthy mice with the treatment of MnFe2O4/TiVNbMoC3-rGD.Micrograph: 10 sections (Heart, Liver, Spleen, Lung, Kidney) in 2x5, Control vs Mne204/TrivNbMoC3-RGD.A composite micrograph figure arranged in 2 rows and 5 columns on a white background. Column titles at the top read Heart, Liver, Spleen, Lung and Kidney. A vertical label along the left margin reads Control aligned with the top row and another vertical label reads Mne204 or TrivNbMoC3-RGD aligned with the bottom row. Each micrograph contains a black scale bar labeled 50 micrometer near the lower right area. The image A showing the Heart micrograph in the Control row. The field is predominantly pink with purple nuclei. Long, parallel, wavy tissue bands run diagonally across the frame. Small, elongated purple nuclei are distributed between the bands. The scale bar reads 50 micrometer. The image B showing the Liver micrograph in the Control row. The field contains densely packed pink and purple cellular tissue with many small purple nuclei throughout. A lighter, rounded structure is located near the upper left region. The scale bar reads 50 micrometer. The image C showing the Spleen micrograph in the Control row. The field contains mixed darker purple regions and lighter pink regions forming irregular patches. Numerous small purple nuclei create a dense granular texture. The scale bar reads 50 micrometer. The image D showing the Lung micrograph in the Control row. Large white open spaces occupy much of the field, separated by thin pink septa with scattered purple nuclei. A thicker pink band crosses the upper portion of the image. The scale bar reads 50 micrometer. The image E showing the Kidney micrograph in the Control row. Multiple rounded and oval tubular profiles with pink walls and purple nuclei are distributed across the field. Several circular structures with denser cellular rings are present, including one near the upper central area. The scale bar reads 50 micrometer. The image F showing the Heart micrograph in the Mne204 or TrivNbMoC3-RGD row. Pink tissue bands run diagonally with a parallel arrangement similar to the top-row Heart image. Purple elongated nuclei are scattered between the bands. The scale bar reads 50 micrometer. The image G showing the Liver micrograph in the Mne204 or TrivNbMoC3-RGD row. The field is densely cellular with many small purple nuclei and pink cytoplasmic background. The texture is relatively uniform across the frame. The scale bar reads 50 micrometer. The image H showing the Spleen micrograph in the Mne204 or TrivNbMoC3-RGD row. Darker purple cellular regions and lighter pink regions form irregular, intermingled areas. Numerous small purple nuclei create a dense pattern across the tissue. The scale bar reads 50 micrometer. The image I showing the Lung micrograph in the Mne204 or TrivNbMoC3-RGD row. Many white open spaces of varying sizes are separated by thin pink septa containing scattered purple nuclei, forming a honeycomb-like pattern across the field. The scale bar reads 50 micrometer. The image J showing the Kidney micrograph in the Mne204 or TrivNbMoC3-RGD row. Multiple tubular profiles with pink walls and purple nuclei are distributed throughout. Rounded structures with denser cellular rings are present, including one near the upper central region. The scale bar reads 50 micrometer. Different concentrations of nanomaterials in hemolysis assay. Histological analysis of major organs of healthy mice with the treatment of MnFe2O4/TiVNbMoC3-rGD. Statistical Analysis SPSS version 22.0 was used for statistical analyses. One-way analysis of variance (ANOVA) or t test for multiple comparisons was used for statistical analysis. All data were expressed as mean±standard deviation (SD). Statistical significance was set at p<0.05, p<0.01 as indicated in the figures. Discussion The continuous advancement of nanotechnology, combined with single-modality therapies, has established Schottky junction nanomaterials as promising agents for the multimodal treatment of bladder cancer.18 The heterostructure of Schottky junction nanomaterials efficiently separates and transports electron-hole pairs upon photo excitation,19 leading to markedly enhanced ROS production.20 This photocatalytic activity can be leveraged to induce ICD in bladder cancer cells,21 while the integrated PTT function provides a dual-action therapeutic strategy that targets malignancies with reduced off-target damage. Pan et al22 constructed a multifunctional nanodiagnostic probe by combining bladder cancer-targeting cyclopeptides, chemotherapeutic drugs, and photosensitizers for PDT, which integrated simultaneous fluorescence imaging, PDT and CDT, providing a comprehensive approach to bladder cancer management. Therefore, employing multimodal treatment, there is potential to overcome the limitations of biologically and clinically heterogeneous and effectively combat tumor drug resistance and immune evasion.23 Building on this foundation, we successfully fabricated a metal-semiconductor nanocomposite, MnFe2O4/TiVNbMoC3-cRGD MXenes. Comprehensive characterization (STEM, EDX, XRD, DLS, XPS) verified its structural integrity and the homogeneous distribution of constituent elements (Ti, V, Nb, C, O).24,25 The material possesses an expanded active surface area, which promotes structural uniformity. Meanwhile, the intimate interfacial contact between the TiVNbMoC3 and MnFe2O4 phases facilitates efficient charge transfer, which is a critical feature underlying its synergistic photodynamic and photothermal capabilities. Furthermore, UV-vis spectroscopy confirmed that incorporating MnFe2O4 substantially modulates the composite’s optical properties, resulting in broadened light absorption across an extended wavelength range and thereby enhancing its suitability for photo-mediated therapies.26 Rationale for MXene selection. Why MXene? The current study designed a MnFe2O4/ TiVNbMoC3-RGD Schottky junction, leveraging the inherent advantages of MXenes as a 2D transition metal carbide family: (1) broad NIR absorption due to localized surface plasmon resonance, enabling efficient photothermal heating under 808 nm laser without extra plasmonic nanoparticles;27 (2) Schottky junction formation when interfaced with MnFe2O4, creating a built‑in electric field that separates electron‑hole pairs and suppresses recombination, thereby boosting ROS generation for PDT/CDT;28 (3) abundant surface groups (–OH, –O, –F) conferring good aqueous dispersibility, facile ligand conjugation (eg, cRGD), and favorable biocompatibility (minimal hemolysis, no organ toxicity at therapeutic doses);29 and (4) high surface area allowing dense MnFe2O4 loading for synergistic PTT/PDT. Specifically, the quinary MXene TiVNbMoC3 was chosen over conventional binary or ternary MXenes (eg, Ti3C2, Nb2C) due to its high compositional entropy. This high‑entropy configuration has been reported to confer even broader optical absorption across the UV-vis-NIR region, enhanced colloidal stability, and improved resistance to oxidation compared to lower entropy MXenes.30 A preliminary screening also indicated that TiVNbMoC3 exhibits a higher photothermal conversion efficiency under 808 nm laser irradiation than Ti3C2, justifying the added synthetic complexity.31 Most significantly, this nanocomposite effectively triggered ICD in bladder cancer cells. This effect was demonstrated by a robust increase in ROS and the upregulation of classical ICD markers-specifically, the surface exposure of CRT and the extracellular release of HMGB1, as confirmed by Western blot analysis.32,33 This finding aligns well with the observed in vivo antitumor efficacy and suppression of colony formation. Furthermore, the migration assay (Figure 14) showed that nanocomposite treatment reduced wound closure to only ~20% (compared to ~95% in controls), confirming its potent anti-invasive activity. Given that bladder cancer progression to muscle‑invasive disease critically depends on tumor cell migration and invasion, this anti‑migratory effect is clinically relevant. Although we did not directly assess metastasis in vivo, the marked reduction in wound closure suggests that this Schottky junction platform may also suppress metastatic dissemination. Future studies using orthotopic or experimental metastasis models (eg, tail vein injection) are warranted to confirm this. Thus, the combination of anti-migratory activity and ICD‑induced adaptive immunity offers a dual mechanism that could potentially reduce both local recurrence and systemic spread—two major clinical challenges in bladder cancer management. Together with results from the colony formation and apoptosis assays, these damage-associated molecular patterns indicate that the nanocomposite can elicit a potent antitumor immune response. Furthermore, in vivo studies demonstrated favorable antitumor effects in a preclinical murine model compared with single-agent DOX chemotherapy, while showing minimal toxicity to vital organs. Collectively, these findings confirm that our platform has dual mode therapeutic action through combined PDT and PTT therapy. Moreover, in vivo studies demonstrated favorable anti-tumor effects in a preclinical murine model compared to single‑agent DOX chemotherapy, with minimal toxicity to vital organs, suggesting its potential for further translational investigation. By simultaneously inhibiting migration and triggering ICD, this targeted nanocomposite addresses not only primary tumor growth but also the risk of progression and metastasis, thereby aligning with the urgent clinical need for more comprehensive bladder cancer therapies. Nevertheless, this study has certain limitations. First, While CRT and HMGB1 confirm ICD, the upstream signaling pathways (eg, ER stress or caspase-dependent mechanisms) were not examined. Emerging evidence has established that therapy-induced ER stress can elicit ICD through the PERK–eIF2α–ATF4–CHOP pathway,34 and that caspase activation plays a dual role in regulating ICD hallmark factors.35 Furthermore, the immunogenicity of the nanocomposite in vivo (eg, T-cell infiltration or cytokine profiling) warrants further study. Nanosphere-mediated cytokine modulation has been shown to increase pro-inflammatory cytokines such as IFN-γ, IL-6, and TNF-α,36 and enhanced CD8+ T cell infiltration has been reported as a critical readout of ICD-driven antitumor immunity.37 Similarly, an FGFR3 -targeting antibody drug conjugate developed by Shu Cui et al38 induced bladder cancer cell apoptosis via activation of the cGAS-STING pathway. These reports suggest that further investigation into the immunomodulatory or pathway-specific mechanisms of our system could help optimize its therapeutic efficacy. Second, the current work focuses on the photothermal and photodynamic properties of the material. However, environmental factors like solution pH and temperature may affect its stability and function. These aspects have not been systematically studied and will be investigated in future research. Third, only a single cell line was employed in this study. Other cell types, such as T24 or UM-UC-3, warrant further inclusion in subsequent research. Moreover, one limitation of this study is the lack of a dedicated “Laser Only” control group. While previous reports using identical 808 nm laser parameters on bladder cancer cells have shown negligible cytotoxicity and no significant tumor growth inhibition in the absence of a PTT agent,39 we cannot completely rule out a minor contribution from direct laser heating. However, the dramatic difference in anti-tumor efficacy between the nanocomposite treated group and the PBS control, together with the minimal temperature rise observed in preliminary thermographic measurements without the nanocomposite (ΔT < 4 °C), strongly suggests that the observed cell death is primarily driven by the nanocomposite’s PTT and PDT effects.40 Future studies will incorporate a “Laser Only” arm to definitively separate the thermal contribution. Conclusion This MXene-based Schottky junction nanocomposite MnFe2O4/TiVNbMoC3-cRGD represents a promising targeted platform for dual-modal photothermal/photodynamic therapy combined with immune activation in bladder cancer, warranting further translational investigation.